Autoinflammatory & rare systemic diseases

Elevated monocyte distribution width in patients with active adult-onset Still's disease: a novel activity indicator

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

Elevated MDW and its positive correlation with inflammatory parameters in AOSD patients indicate MDW as a novel activity indicator, with a high MDW value above 21.7 linked to a high probability of active AOSD.

Study context

Population
Patients with adult-onset Still's disease (AOSD) and patients with COVID-19 as disease control58 AOSD, 95 COVID-19
Exposure
Active AOSD vs inactive AOSD vs non-severe COVID-19
Outcome
Associations between MDW and disease activity or inflammatory parameters in AOSD
Methodological detailsdisease control (COVID-19), longitudinal follow-up
  • Disease control (COVID-19)
  • Longitudinal follow-up

Main finding

As reported in the abstract

MDW

Active AOSD

28.3

median · IQR 23.3–32.1

Inactive AOSD

19.2

IQR 18.0–20.6

Non-severe COVID-19

23.2

IQR 21.0–25.2

Active AOSD vs Inactive AOSD: P < 0.001 · Active AOSD vs Non-severe COVID-19: P < 0.01

Observational data: associations, not effects.

Further findings

OutcomeValues
MDW threshold 21.7 to predict active AOSDMDW >21.7 sensitivity 91.3% · specificity 94.3%

Median monocyte distribution width (MDW) on longitudinal follow-up in AOSD

Median MDW declined 28.3 vs 18.5 along with disease activity, paralleling decrease in C-reactive protein (CRP) and ferritin
P < 0.001

MDW in severe COVID-19 and sepsis

Elevated MDW, not different from active AOSD

MDW threshold 21.7 to predict active AOSD

MDW a significant predictor of active AOSD in multivariate analysis

Original publication

Elevated monocyte distribution width in patients with active adult-onset Still's disease: a novel activity indicator. Clin Exp Rheumatol. Published 15 February 2023. doi:10.55563/clinexprheumatol/jbm7pb

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.